What You Should Know:
– Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces today the launch of its first therapy selection test, the My Phenome Hungry Gut test.
– This is a first-of-its-kind obesity test and will determine if a patient’s phenotype is Hungry Gut (Satiety) or feeling hungry shortly after eating a meal. If a patient is Hungry Gut phenotyped, providers are able to more precisely and accurately make a treatment plan which would include a diet intervention specific to Hungry Gut, GLP-1 (glucagon-like peptide) medications, and intragastric balloons.
– The Hungry Gut Test will initially be rolled out to a select group of providers before a full roll-out later this year.
